Coronavirus Vaccine - Global Market Outlook (2018-2027)

   |      |      |  

Coronavirus Vaccine - Global Market Outlook (2018-2027)

"The Global Coronavirus Vaccine Market is accounted for $18.69 million in 2018 and is expected to reach $900.14 million by 2027 growing at a CAGR of 53.8% during the forecast period. The increasing prevalence of virus infected people across the world is anticipated to drive the growth of the market. However, factors such as high cost involved in research and development of therapeutic vaccines and drugs, and time required for each stage of clinical trials are hampering the market growth.

Corona viruses are a group of viruses which cause diseases or infections in mammals as well as birds. Coronaviruses belong to the Coronaviridae or Torovirinae subfamily. Symptoms caused by these viruses include common cold to serious infections, pneumonia, strict respiratory complications, even kidney failure, and death. These symptoms are common among persons with a weak immune system, individuals with cardiopulmonary disease, infants, and elderly people.

Based on the vaccine type, the DNA-based vaccine segment is going to have a lucrative growth during the forecast period the technological advancements in the field of pharmaceutical industry have resulted in development of various effective type of vaccines such as DNA-based nucleic acid vaccines. The use of these vaccines on human body leads to development of anti-gen. Thus, the effectiveness of the vaccine against the virus is enhanced significantly.

By geography, Europe is likely to have a huge demand due to diverse coronavirus outbreaks in the current past and presence of major players in countries in the region. As well, rising investments in R&D activities, along with strong support from the government is driving the growth of the target market in this region.

Some of the key players profiled in the Coronavirus Vaccine Market include Inovio Pharmaceuticals, Inc., Moderna, Inc., Protein Potential, LLC, Novavax, Inc., Synairgen PLC, AlphaVax, Inc., NanoViricides, Inc., Zydus Cadila, Bravovax, GeoVax, Altimmune, Janssen Pharmaceutical Companies, CanSino Biologics, Vaxart and Vaxil Bio Ltd.


Infection Types Covered:
• HCoV-229E
• HCoV-OC43
• HKU1-CoV
• MERS-CoV
• New Haven CoV
• SARS-CoV

Vaccine Types Covered:
• S-Protein Based Coronavirus Vaccine
• Live Attenuated Coronavirus Vaccine
• Inactivated Coronavirus Vaccine
• mRNA Vaccine
• DNA-Based Vaccine

Product Types Covered:
• Monovalent Vaccine v/s Multivariant Vaccine

Route of Administrations Covered:
• Subcutaneous
• Oral
• Intramuscular

Patient Types Covered:
• Pediatric
• Adult

End Users Covered:
• Clinics
• Hospitals
• Research Institutes

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2017, 2018, 2019, 2023 and 2027
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
"

"1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 End User Analysis
3.7 Emerging Markets
3.8 Impact of Covid-19

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Coronavirus Vaccine Market, By Infection Type
5.1 Introduction
5.2 HCoV-229E
5.3 HCoV-OC43
5.4 HKU1-CoV
5.5 MERS-CoV
5.6 New Haven CoV
5.7 SARS-CoV

6 Global Coronavirus Vaccine Market, By Vaccine Type
6.1 Introduction
6.2 S-Protein Based Coronavirus Vaccine
6.3 Live Attenuated Coronavirus Vaccine
6.4 Inactivated Coronavirus Vaccine
6.5 mRNA Vaccine
6.6 DNA-Based Vaccine

7 Global Coronavirus Vaccine Market, By Product Type
7.1 Introduction
7.2 Monovalent Vaccine v\/s Multivariant Vaccine

8 Global Coronavirus Vaccine Market, By Route of Administration
8.1 Introduction
8.2 Subcutaneous
8.3 Oral
8.4 Intramuscular

9 Global Coronavirus Vaccine Market, By Patient Type
9.1 Introduction
9.2 Pediatric
9.3 Adult

10 Global Coronavirus Vaccine Market, By End User
10.1 Introduction
10.2 Clinics
10.3 Hospitals
10.4 Research Institutes

11 Global Coronavirus Vaccine Market, By Geography
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 Germany
11.3.2 UK
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia Pacific
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Australia
11.4.5 New Zealand
11.4.6 South Korea
11.4.7 Rest of Asia Pacific
11.5 South America
11.5.1 Argentina
11.5.2 Brazil
11.5.3 Chile
11.5.4 Rest of South America
11.6 Middle East & Africa
11.6.1 Saudi Arabia
11.6.2 UAE
11.6.3 Qatar
11.6.4 South Africa
11.6.5 Rest of Middle East & Africa

12 Key Developments
12.1 Agreements, Partnerships, Collaborations and Joint Ventures
12.2 Acquisitions & Mergers
12.3 New Product Launch
12.4 Expansions
12.5 Other Key Strategies

13 Company Profiling
13.1 Inovio Pharmaceuticals, Inc.
13.2 Moderna, Inc.
13.3 Protein Potential, LLC
13.4 Novavax, Inc.
13.5 Synairgen PLC
13.6 AlphaVax, Inc.
13.7 NanoViricides, Inc.
13.8 Zydus Cadila
13.9 Bravovax
13.10 GeoVax
13.11 Altimmune
13.12 Janssen Pharmaceutical Companies
13.13 CanSino Biologics
13.14 Vaxart
13.15 Vaxil Bio Ltd

List of Tables
Table 1 Global Coronavirus Vaccine Market Outlook, By Region (2017-2027) ($MN)
Table 2 Global Coronavirus Vaccine Market Outlook, By Infection Type (2017-2027) ($MN)
Table 3 Global Coronavirus Vaccine Market Outlook, By HCoV-229E (2017-2027) ($MN)
Table 4 Global Coronavirus Vaccine Market Outlook, By HCoV-OC43 (2017-2027) ($MN)
Table 5 Global Coronavirus Vaccine Market Outlook, By HKU1-CoV (2017-2027) ($MN)
Table 6 Global Coronavirus Vaccine Market Outlook, By MERS-CoV (2017-2027) ($MN)
Table 7 Global Coronavirus Vaccine Market Outlook, By New Haven CoV (2017-2027) ($MN)
Table 8 Global Coronavirus Vaccine Market Outlook, By SARS-CoV (2017-2027) ($MN)
Table 9 Global Coronavirus Vaccine Market Outlook, By Vaccine Type (2017-2027) ($MN)
Table 10 Global Coronavirus Vaccine Market Outlook, By S-Protein Based Coronavirus Vaccine (2017-2027) ($MN)
Table 11 Global Coronavirus Vaccine Market Outlook, By Live Attenuated Coronavirus Vaccine (2017-2027) ($MN)
Table 12 Global Coronavirus Vaccine Market Outlook, By Inactivated Coronavirus Vaccine (2017-2027) ($MN)
Table 13 Global Coronavirus Vaccine Market Outlook, By mRNA Vaccine (2017-2027) ($MN)
Table 14 Global Coronavirus Vaccine Market Outlook, By DNA-Based Vaccine (2017-2027) ($MN)
Table 15 Global Coronavirus Vaccine Market Outlook, By Product Type (2017-2027) ($MN)
Table 16 Global Coronavirus Vaccine Market Outlook, By Monovalent Vaccine v\/s Multivariant Vaccine (2017-2027) ($MN)
Table 17 Global Coronavirus Vaccine Market Outlook, By Route of Administration (2017-2027) ($MN)
Table 18 Global Coronavirus Vaccine Market Outlook, By Subcutaneous (2017-2027) ($MN)
Table 19 Global Coronavirus Vaccine Market Outlook, By Oral (2017-2027) ($MN)
Table 20 Global Coronavirus Vaccine Market Outlook, By Intramuscular (2017-2027) ($MN)
Table 21 Global Coronavirus Vaccine Market Outlook, By Patient Type (2017-2027) ($MN)
Table 22 Global Coronavirus Vaccine Market Outlook, By Pediatric (2017-2027) ($MN)
Table 23 Global Coronavirus Vaccine Market Outlook, By Adult (2017-2027) ($MN)
Table 24 Global Coronavirus Vaccine Market Outlook, By End User (2017-2027) ($MN)
Table 25 Global Coronavirus Vaccine Market Outlook, By Clinics (2017-2027) ($MN)
Table 26 Global Coronavirus Vaccine Market Outlook, By Hospitals (2017-2027) ($MN)
Table 27 Global Coronavirus Vaccine Market Outlook, By Research Institutes (2017-2027) ($MN)
Table 28 North America Coronavirus Vaccine Market Outlook, By Country (2017-2027) ($MN)
Table 29 North America Coronavirus Vaccine Market Outlook, By Infection Type (2017-2027) ($MN)
Table 30 North America Coronavirus Vaccine Market Outlook, By HCoV-229E (2017-2027) ($MN)
Table 31 North America Coronavirus Vaccine Market Outlook, By HCoV-OC43 (2017-2027) ($MN)
Table 32 North America Coronavirus Vaccine Market Outlook, By HKU1-CoV (2017-2027) ($MN)
Table 33 North America Coronavirus Vaccine Market Outlook, By MERS-CoV (2017-2027) ($MN)
Table 34 North America Coronavirus Vaccine Market Outlook, By New Haven CoV (2017-2027) ($MN)
Table 35 North America Coronavirus Vaccine Market Outlook, By SARS-CoV (2017-2027) ($MN)
Table 36 North America Coronavirus Vaccine Market Outlook, By Vaccine Type (2017-2027) ($MN)
Table 37 North America Coronavirus Vaccine Market Outlook, By S-Protein Based Coronavirus Vaccine (2017-2027) ($MN)
Table 38 North America Coronavirus Vaccine Market Outlook, By Live Attenuated Coronavirus Vaccine (2017-2027) ($MN)
Table 39 North America Coronavirus Vaccine Market Outlook, By Inactivated Coronavirus Vaccine (2017-2027) ($MN)
Table 40 North America Coronavirus Vaccine Market Outlook, By mRNA Vaccine (2017-2027) ($MN)
Table 41 North America Coronavirus Vaccine Market Outlook, By DNA-Based Vaccine (2017-2027) ($MN)
Table 42 North America Coronavirus Vaccine Market Outlook, By Product Type (2017-2027) ($MN)
Table 43 North America Coronavirus Vaccine Market Outlook, By Monovalent Vaccine v\/s Multivariant Vaccine (2017-2027) ($MN)
Table 44 North America Coronavirus Vaccine Market Outlook, By Route of Administration (2017-2027) ($MN)
Table 45 North America Coronavirus Vaccine Market Outlook, By Subcutaneous (2017-2027) ($MN)
Table 46 North America Coronavirus Vaccine Market Outlook, By Oral (2017-2027) ($MN)
Table 47 North America Coronavirus Vaccine Market Outlook, By Intramuscular (2017-2027) ($MN)
Table 48 North America Coronavirus Vaccine Market Outlook, By Patient Type (2017-2027) ($MN)
Table 49 North America Coronavirus Vaccine Market Outlook, By Pediatric (2017-2027) ($MN)
Table 50 North America Coronavirus Vaccine Market Outlook, By Adult (2017-2027) ($MN)
Table 51 North America Coronavirus Vaccine Market Outlook, By End User (2017-2027) ($MN)
Table 52 North America Coronavirus Vaccine Market Outlook, By Clinics (2017-2027) ($MN)
Table 53 North America Coronavirus Vaccine Market Outlook, By Hospitals (2017-2027) ($MN)
Table 54 North America Coronavirus Vaccine Market Outlook, By Research Institutes (2017-2027) ($MN)
Table 55 Europe Coronavirus Vaccine Market Outlook, By Country (2017-2027) ($MN)
Table 56 Europe Coronavirus Vaccine Market Outlook, By Infection Type (2017-2027) ($MN)
Table 57 Europe Coronavirus Vaccine Market Outlook, By HCoV-229E (2017-2027) ($MN)
Table 58 Europe Coronavirus Vaccine Market Outlook, By HCoV-OC43 (2017-2027) ($MN)
Table 59 Europe Coronavirus Vaccine Market Outlook, By HKU1-CoV (2017-2027) ($MN)
Table 60 Europe Coronavirus Vaccine Market Outlook, By MERS-CoV (2017-2027) ($MN)
Table 61 Europe Coronavirus Vaccine Market Outlook, By New Haven CoV (2017-2027) ($MN)
Table 62 Europe Coronavirus Vaccine Market Outlook, By SARS-CoV (2017-2027) ($MN)
Table 63 Europe Coronavirus Vaccine Market Outlook, By Vaccine Type (2017-2027) ($MN)
Table 64 Europe Coronavirus Vaccine Market Outlook, By S-Protein Based Coronavirus Vaccine (2017-2027) ($MN)
Table 65 Europe Coronavirus Vaccine Market Outlook, By Live Attenuated Coronavirus Vaccine (2017-2027) ($MN)
Table 66 Europe Coronavirus Vaccine Market Outlook, By Inactivated Coronavirus Vaccine (2017-2027) ($MN)
Table 67 Europe Coronavirus Vaccine Market Outlook, By mRNA Vaccine (2017-2027) ($MN)
Table 68 Europe Coronavirus Vaccine Market Outlook, By DNA-Based Vaccine (2017-2027) ($MN)
Table 69 Europe Coronavirus Vaccine Market Outlook, By Product Type (2017-2027) ($MN)
Table 70 Europe Coronavirus Vaccine Market Outlook, By Monovalent Vaccine v\/s Multivariant Vaccine (2017-2027) ($MN)
Table 71 Europe Coronavirus Vaccine Market Outlook, By Route of Administration (2017-2027) ($MN)
Table 72 Europe Coronavirus Vaccine Market Outlook, By Subcutaneous (2017-2027) ($MN)
Table 73 Europe Coronavirus Vaccine Market Outlook, By Oral (2017-2027) ($MN)
Table 74 Europe Coronavirus Vaccine Market Outlook, By Intramuscular (2017-2027) ($MN)
Table 75 Europe Coronavirus Vaccine Market Outlook, By Patient Type (2017-2027) ($MN)
Table 76 Europe Coronavirus Vaccine Market Outlook, By Pediatric (2017-2027) ($MN)
Table 77 Europe Coronavirus Vaccine Market Outlook, By Adult (2017-2027) ($MN)
Table 78 Europe Coronavirus Vaccine Market Outlook, By End User (2017-2027) ($MN)
Table 79 Europe Coronavirus Vaccine Market Outlook, By Clinics (2017-2027) ($MN)
Table 80 Europe Coronavirus Vaccine Market Outlook, By Hospitals (2017-2027) ($MN)
Table 81 Europe Coronavirus Vaccine Market Outlook, By Research Institutes (2017-2027) ($MN)
Table 82 Asia Pacific Coronavirus Vaccine Market Outlook, By Country (2017-2027) ($MN)
Table 83 Asia Pacific Coronavirus Vaccine Market Outlook, By Infection Type (2017-2027) ($MN)
Table 84 Asia Pacific Coronavirus Vaccine Market Outlook, By HCoV-229E (2017-2027) ($MN)
Table 85 Asia Pacific Coronavirus Vaccine Market Outlook, By HCoV-OC43 (2017-2027) ($MN)
Table 86 Asia Pacific Coronavirus Vaccine Market Outlook, By HKU1-CoV (2017-2027) ($MN)
Table 87 Asia Pacific Coronavirus Vaccine Market Outlook, By MERS-CoV (2017-2027) ($MN)
Table 88 Asia Pacific Coronavirus Vaccine Market Outlook, By New Haven CoV (2017-2027) ($MN)
Table 89 Asia Pacific Coronavirus Vaccine Market Outlook, By SARS-CoV (2017-2027) ($MN)
Table 90 Asia Pacific Coronavirus Vaccine Market Outlook, By Vaccine Type (2017-2027) ($MN)
Table 91 Asia Pacific Coronavirus Vaccine Market Outlook, By S-Protein Based Coronavirus Vaccine (2017-2027) ($MN)
Table 92 Asia Pacific Coronavirus Vaccine Market Outlook, By Live Attenuated Coronavirus Vaccine (2017-2027) ($MN)
Table 93 Asia Pacific Coronavirus Vaccine Market Outlook, By Inactivated Coronavirus Vaccine (2017-2027) ($MN)
Table 94 Asia Pacific Coronavirus Vaccine Market Outlook, By mRNA Vaccine (2017-2027) ($MN)
Table 95 Asia Pacific Coronavirus Vaccine Market Outlook, By DNA-Based Vaccine (2017-2027) ($MN)
Table 96 Asia Pacific Coronavirus Vaccine Market Outlook, By Product Type (2017-2027) ($MN)
Table 97 Asia Pacific Coronavirus Vaccine Market Outlook, By Monovalent Vaccine v\/s Multivariant Vaccine (2017-2027) ($MN)
Table 98 Asia Pacific Coronavirus Vaccine Market Outlook, By Route of Administration (2017-2027) ($MN)
Table 99 Asia Pacific Coronavirus Vaccine Market Outlook, By Subcutaneous (2017-2027) ($MN)
Table 100 Asia Pacific Coronavirus Vaccine Market Outlook, By Oral (2017-2027) ($MN)
Table 101 Asia Pacific Coronavirus Vaccine Market Outlook, By Intramuscular (2017-2027) ($MN)
Table 102 Asia Pacific Coronavirus Vaccine Market Outlook, By Patient Type (2017-2027) ($MN)
Table 103 Asia Pacific Coronavirus Vaccine Market Outlook, By Pediatric (2017-2027) ($MN)
Table 104 Asia Pacific Coronavirus Vaccine Market Outlook, By Adult (2017-2027) ($MN)
Table 105 Asia Pacific Coronavirus Vaccine Market Outlook, By End User (2017-2027) ($MN)
Table 106 Asia Pacific Coronavirus Vaccine Market Outlook, By Clinics (2017-2027) ($MN)
Table 107 Asia Pacific Coronavirus Vaccine Market Outlook, By Hospitals (2017-2027) ($MN)
Table 108 Asia Pacific Coronavirus Vaccine Market Outlook, By Research Institutes (2017-2027) ($MN)
Table 109 South America Coronavirus Vaccine Market Outlook, By Country (2017-2027) ($MN)
Table 110 South America Coronavirus Vaccine Market Outlook, By Infection Type (2017-2027) ($MN)
Table 111 South America Coronavirus Vaccine Market Outlook, By HCoV-229E (2017-2027) ($MN)
Table 112 South America Coronavirus Vaccine Market Outlook, By HCoV-OC43 (2017-2027) ($MN)
Table 113 South America Coronavirus Vaccine Market Outlook, By HKU1-CoV (2017-2027) ($MN)
Table 114 South America Coronavirus Vaccine Market Outlook, By MERS-CoV (2017-2027) ($MN)
Table 115 South America Coronavirus Vaccine Market Outlook, By New Haven CoV (2017-2027) ($MN)
Table 116 South America Coronavirus Vaccine Market Outlook, By SARS-CoV (2017-2027) ($MN)
Table 117 South America Coronavirus Vaccine Market Outlook, By Vaccine Type (2017-2027) ($MN)
Table 118 South America Coronavirus Vaccine Market Outlook, By S-Protein Based Coronavirus Vaccine (2017-2027) ($MN)
Table 119 South America Coronavirus Vaccine Market Outlook, By Live Attenuated Coronavirus Vaccine (2017-2027) ($MN)
Table 120 South America Coronavirus Vaccine Market Outlook, By Inactivated Coronavirus Vaccine (2017-2027) ($MN)
Table 121 South America Coronavirus Vaccine Market Outlook, By mRNA Vaccine (2017-2027) ($MN)
Table 122 South America Coronavirus Vaccine Market Outlook, By DNA-Based Vaccine (2017-2027) ($MN)
Table 123 South America Coronavirus Vaccine Market Outlook, By Product Type (2017-2027) ($MN)
Table 124 South America Coronavirus Vaccine Market Outlook, By Monovalent Vaccine v\/s Multivariant Vaccine (2017-2027) ($MN)
Table 125 South America Coronavirus Vaccine Market Outlook, By Route of Administration (2017-2027) ($MN)
Table 126 South America Coronavirus Vaccine Market Outlook, By Subcutaneous (2017-2027) ($MN)
Table 127 South America Coronavirus Vaccine Market Outlook, By Oral (2017-2027) ($MN)
Table 128 South America Coronavirus Vaccine Market Outlook, By Intramuscular (2017-2027) ($MN)
Table 129 South America Coronavirus Vaccine Market Outlook, By Patient Type (2017-2027) ($MN)
Table 130 South America Coronavirus Vaccine Market Outlook, By Pediatric (2017-2027) ($MN)
Table 131 South America Coronavirus Vaccine Market Outlook, By Adult (2017-2027) ($MN)
Table 132 South America Coronavirus Vaccine Market Outlook, By End User (2017-2027) ($MN)
Table 133 South America Coronavirus Vaccine Market Outlook, By Clinics (2017-2027) ($MN)
Table 134 South America Coronavirus Vaccine Market Outlook, By Hospitals (2017-2027) ($MN)
Table 135 South America Coronavirus Vaccine Market Outlook, By Research Institutes (2017-2027) ($MN)
Table 136 Middle East & Africa Coronavirus Vaccine Market Outlook, By Country (2017-2027) ($MN)
Table 137 Middle East & Africa Coronavirus Vaccine Market Outlook, By Infection Type (2017-2027) ($MN)
Table 138 Middle East & Africa Coronavirus Vaccine Market Outlook, By HCoV-229E (2017-2027) ($MN)
Table 139 Middle East & Africa Coronavirus Vaccine Market Outlook, By HCoV-OC43 (2017-2027) ($MN)
Table 140 Middle East & Africa Coronavirus Vaccine Market Outlook, By HKU1-CoV (2017-2027) ($MN)
Table 141 Middle East & Africa Coronavirus Vaccine Market Outlook, By MERS-CoV (2017-2027) ($MN)
Table 142 Middle East & Africa Coronavirus Vaccine Market Outlook, By New Haven CoV (2017-2027) ($MN)
Table 143 Middle East & Africa Coronavirus Vaccine Market Outlook, By SARS-CoV (2017-2027) ($MN)
Table 144 Middle East & Africa Coronavirus Vaccine Market Outlook, By Vaccine Type (2017-2027) ($MN)
Table 145 Middle East & Africa Coronavirus Vaccine Market Outlook, By S-Protein Based Coronavirus Vaccine (2017-2027) ($MN)
Table 146 Middle East & Africa Coronavirus Vaccine Market Outlook, By Live Attenuated Coronavirus Vaccine (2017-2027) ($MN)
Table 147 Middle East & Africa Coronavirus Vaccine Market Outlook, By Inactivated Coronavirus Vaccine (2017-2027) ($MN)
Table 148 Middle East & Africa Coronavirus Vaccine Market Outlook, By mRNA Vaccine (2017-2027) ($MN)
Table 149 Middle East & Africa Coronavirus Vaccine Market Outlook, By DNA-Based Vaccine (2017-2027) ($MN)
Table 150 Middle East & Africa Coronavirus Vaccine Market Outlook, By Product Type (2017-2027) ($MN)
Table 151 Middle East & Africa Coronavirus Vaccine Market Outlook, By Monovalent Vaccine v\/s Multivariant Vaccine (2017-2027) ($MN)
Table 152 Middle East & Africa Coronavirus Vaccine Market Outlook, By Route of Administration (2017-2027) ($MN)
Table 153 Middle East & Africa Coronavirus Vaccine Market Outlook, By Subcutaneous (2017-2027) ($MN)
Table 154 Middle East & Africa Coronavirus Vaccine Market Outlook, By Oral (2017-2027) ($MN)
Table 155 Middle East & Africa Coronavirus Vaccine Market Outlook, By Intramuscular (2017-2027) ($MN)
Table 156 Middle East & Africa Coronavirus Vaccine Market Outlook, By Patient Type (2017-2027) ($MN)
Table 157 Middle East & Africa Coronavirus Vaccine Market Outlook, By Pediatric (2017-2027) ($MN)
Table 158 Middle East & Africa Coronavirus Vaccine Market Outlook, By Adult (2017-2027) ($MN)
Table 159 Middle East & Africa Coronavirus Vaccine Market Outlook, By End User (2017-2027) ($MN)
Table 160 Middle East & Africa Coronavirus Vaccine Market Outlook, By Clinics (2017-2027) ($MN)
Table 161 Middle East & Africa Coronavirus Vaccine Market Outlook, By Hospitals (2017-2027) ($MN)
Table 162 Middle East & Africa Coronavirus Vaccine Market Outlook, By Research Institutes (2017-2027) ($MN)
"

Coronavirus Vaccine - Global Market Outlook (2018-2027)

.